During the Option Term. (a) Silence shall not (and shall ensure that its Affiliates do not) license, sublicense, transfer, assign or take any other action with respect to any Silence Background IP, Silence Research IP, or Silence’s interest in the Joint Research IP that would be inconsistent with or prevent Silence from granting the license under Section 4.1.2 in respect of any Complement Target and (b) neither Party shall (and shall ensure that its Affiliates do not), itself or with or through a Third Party, Exploit any [***] and/or [***].
Appears in 2 contracts
Sources: License and Collaboration Agreement (Silence Therapeutics PLC), License and Collaboration Agreement (Silence Therapeutics PLC)